FDA — authorised 2 April 1965
- Marketing authorisation holder: ARBOR PHARMS LLC
- Status: approved
🇺🇸 Eryped in United States
FDA authorised Eryped on 2 April 1965
Marketing authorisations
FDA — authorised 2 April 1965
- Application: NDA050207
- Marketing authorisation holder: CARNEGIE
- Local brand name: ERYPED
- Indication: GRANULE — ORAL
- Status: approved
FDA — authorised 6 August 1970
- Application: NDA050297
- Marketing authorisation holder: AZURITY
- Local brand name: ERYPED
- Indication: TABLET, CHEWABLE — ORAL
- Status: approved
Eryped in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Eryped approved in United States?
Yes. FDA authorised it on 2 April 1965; FDA authorised it on 2 April 1965; FDA authorised it on 6 August 1970.
Who is the marketing authorisation holder for Eryped in United States?
ARBOR PHARMS LLC holds the US marketing authorisation.